TMCnet News

Research and Markets: Global Uterine Cancer Clinical Trials Review, H2, 2013
[December 09, 2013]

Research and Markets: Global Uterine Cancer Clinical Trials Review, H2, 2013


DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/pqpbsc/uterine_cancer) has announced the addition of the "Global Uterine Cancer Clinical Trials Review, H2, 2013" report to their offering.

Our clinical trial report provides data on the Uterine Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Uterine Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe.

The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trialsfor the key drugs for treating Uterine Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.



Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Key Topics Covered:


Table of Contents

List of Tables

Introduction

Uterine Cancer

Report Guidance

Clinical Trials by Region

Clinical Trials by Country

Top Five Countries Contributing to Clinical Trials in Asia-Pacific

Top Five Countries Contributing to Clinical Trials in Europe

Top Countries Contributing to Clinical Trials in North America

Top Five Countries Contributing to Clinical Trials in Middle East and Africa

Top Five Countries Contributing to Clinical Trials in Central and South America

Clinical Trials

Prominent Sponsors

Top Companies Participating in Uterine Cancer Therapeutics Clinical Trials

Clinical Trial Overview of Top Companies

Appendix

For more information visit http://www.researchandmarkets.com/research/pqpbsc/uterine_cancer


[ Back To TMCnet.com's Homepage ]